AstraZeneca

BXP has completed the sale of a 45 percent interest in 290 Binney St., a life science development in Kendall Square in Cambridge, Mass.

BXP Closes Sale of Minority Interest in Life Science Building

The transaction reduces the company’s development cost by upward of $500 million.

Rendering of Matan Cos.' recently built life science property.

AstraZeneca Expands Near DC With 198 KSF Lease

Owner Matan Cos. recently delivered the building as part of a 44-acre campus.

AGC Biologics Buys 300KSF Boulder Plant

The global pharmaceutical company will invest $100 million to transform the Colorado facility, which had been owned and occupied by AstraZeneca.

Capital One Shells Out $46M for Office Campus Acquisition

Earlier this year, U.K.-based AstraZeneca sold its U.S. headquarters in New Castle County to an affiliate of Delle Donne & Associates in a deal valued at $50 million, or $48.47 per square foot.